This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0560U only for Haystack MRD™ Baseline from Quest Diagnostics®. This test uses genomic sequence analysis of tumor tissue and whole blood to create a personalized variant panel. The panel helps detect minimal residual disease (MRD), which refers to small amounts of cancer cells remaining after treatment, and serves as a baseline for future MRD assessments.
For clinical responsibility, terminology, tips and additional info
start codify free trial.